logo
Share SHARE
FONT-SIZE Plus   Neg

Isotechnika Pharma Obtains Notice Of ILJIN's Request For Arbitration

Isotechnika Pharma Inc. (ISA.TO) announced that it has received notification that ILJIN Life Science Co., Ltd. has submitted a request for arbitration relating to Isotechnika's termination of their Development, Distribution and License Agreement or "DDL".

"We are confident that our termination of the original DDL is valid, and are prepared for arbitration proceedings. We plan on continuing to engage companies, including ILJIN, who have expressed interest in working with us to advance our lead program," said Robert Foster, Isotechnika's CEO.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Anglo-Dutch oil giant Royal Dutch Shell plans to cut 2,200 more jobs, as the company continues to face lower oil prices, media reported Wednesday citing an emailed statement. The latest round of cuts would bring the total job cuts this year to at least 5,000 globally. In the U.K. and Ireland, the company plans to reduce staff working in exploration and production by 475. Tiffany & Co. (TIF) reported first-quarter net earnings of $87 million, or $0.69 per share compared to $105 million, or $0.81 per share, in the prior year. The company noted that its first-quarter results included a tax benefit of $0.05 per share related to the settlement of a tax examination. On average,... Shares of Marks & Spencer Group plc were losing around 8 percent in the early morning trading in London, after the retailer reported lower profit in its fiscal 2016, hurt mainly by weak results at clothing & Home segment and lower UK LFL sales. Looking ahead, the company warned about profit, and said it sees a similar sales trend in fiscal 2017.
comments powered by Disqus
Follow RTT